As of 2024-12-12, the Intrinsic Value of Passage Bio Inc (PASG) is
-5.57 USD. This PASG valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.76 USD, the upside of Passage Bio Inc is
-834.70%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-5.57 USD
Intrinsic Value
PASG Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-5.57 - -5.57 |
-5.57 |
-834.70% |
| P/E |
(31.34) - (34.82) |
(30.74) |
-4155.6% |
| DDM - Stable |
(6.54) - (17.69) |
(12.12) |
-1698.5% |
| DDM - Multi |
(0.16) - (0.32) |
(0.21) |
-127.8% |
PASG Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
46.82 |
| Beta |
2.16 |
| Outstanding shares (mil) |
61.77 |
| Enterprise Value (mil) |
14.53 |
| Market risk premium |
4.60% |
| Cost of Equity |
12.79% |
| Cost of Debt |
5.00% |
| WACC |
8.23% |